Abstract
Human papillomavirus (HPV) infections of the anogenital tract present several difficult questions pertaining to diagnosis. The most obvious question is whether a test for papillomavirus in anogenital lesions is necessary, and if so, what information is desired from such a test. If a diagnostic test is sought, then the next problem concerns the multitude of different papillomavirus types found in anogenital tract lesions, the need, if any, to differentiate these multiple types, and the availability of diagnostic probes to do so. The following discussion will elucidate the arguments supporting the need to test for HPV, by briefly describing a number of epidemiologic studies which associate HPV DNA with premalignant and malignant anogenital tract lesions. Molecular biological data which demonstrates the ability of certain papillomaviruses to transform cells in culture will also be reviewed. In addition, the ways in which nucleic acid hybridization techniques apply to the detection of HPV infections will be described, as well as advantages and disadvantages of several different hybridization techniques which can be used to HPV detection in anogenital lesions.
Keywords
- Uterine Cervix
- Nucleic Acid Hybridization
- Anogenital Lesion
- Genital Condyloma
- Nucleic Acid Hybridization Technique
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Androphy, E.J., D.R. Lowry, and J.T. Schiller, Bovine papillomavirus E2 transactivating gene product binds to specific sites in papillomavirus DNA, Nature. 325:70–73 (1987).
Baker, C.C., and P.M. Howley, Differential promotor utilization by the bovine papillomavirus in transformed cells and productively infected wart tissued, EMBO J. 6:1027–1035 (1987).
Baker, C.C., W.C. Phelps, V. Lindgren, M.J. Braun, M.A. Gonda, and P.M. Howley, Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines, J. Virol. 61:962–971 (1987).
Beaudenon, S., D. Kremsdorf, O. Croissant, S. Jablonska, S. Wain-Hobson, and G. Orth, A novel type of human papillomavirus associated with genital neoplasia, Nature. 321:246–249 (1986).
Becker, T.M., K.M. Stone, and E.R. Alexander, Genital human papillomaviurs Infection: A growing concern, p. 389–396, in: “Obstetrics and Gynecology Clinics of North America,” R. Reid, ed., vol. 14:2, W.B. Saunders Co., Philadelphia (1987).
Beckmann, A.M., D. Myerson, J.R. Daling, N.B. Kiviat, C.M. Fenoglio, and J.K. McDougall, Detection and localization of human papillomavirus DNA in human genital condylomas by in situ hybridization with biotinylated probes, J. Med. Virol. 16:265–273 (1985).
Berg, L.J., K. Singh, and M. Botchan, Complementation of a bovine papillomavirus low-copy-number mutant: Evidence for a temporal requirement of the complementing gene, Mol. Cell. Biol. 6:859–869 (1986).
Boshardt, M., L. Gissmann, H. Ikenberg, A. Kleinheinz, W. Schewlen, and H. zur Hausen, A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer, EMBO 3:1151–1157 (1984).
Boshart, M., and H. zur Hausen, Human papillomaviruses in BuschkeLowenstein tumors: Physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype, J. Virol. 58:963–966 (1986).
Byrne, J.C., M.S. Tsao, R.S. Fraser, and P.M. Howley, Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung, New England J. of Med. 317:873–878 (1987).
Campion, M.J., Clinical manifestations and natural history of genital human papillomavirus infections, p. 363–388, in: “Obstetrics and Gynecology Clinics of North America,” R. Reid, ed., vol. 14:2, W.B. Saunders Co., Philadelphia (1987).
Cole, S.T., and O. Danos, Nuclotide sequence and comparative analysis of the human papillomavirus type 18 genome: Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products, J. Mol. Biol. 193:599–608 (1987).
Cole, S.T., and R.E. Streek, Genome organization and nucleotide sequence in human paillomavirus type 33, which is associated with cervical cancer, J. Virol. 58:991–995 (1986).
Chow, L.T., M. Nasseri, S.M. Wolinsky, and T.R. Broker, Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata, J. Virol. 61:2581–2583 (1987).
DiMaio, D., D. Guralski, and J.T. Schiller, Translation of open reading frame E5 of bovine paillomavirus is required for its transforming activity, Proc. Natl. Acad. Sci. USA 83:1797–1801 (1986).
Doorbar, J., D. Campbell, R.J. Grand, and P.H. Gallimore, Identification of the human papillomavirus-la E4 gene products, EMBO J. 5:355362 (1986).
Durst, M., C.M. Croce, L. Gissmann, et al., Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas, Proc. Natl. Acad. Sci. USA 84:1070–1074 (1987).
Durst, M., A. Kleinheinz, M. Hotz, and L. Gissmann, The physical state of human papillomavirus type 16 DNA in benign and malignant tumors, J. Gen. Virol. 66:1515–1522 (1985).
Durst, M., L. Gissmann, H. Ikenberg, and H. zur Hausen, A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsies from different geographic regions, Proc. Natl. Acad. Sci. USA 80:3812–3815 (1983).
Gissmann, L., M. Boshart, M. Durst, H. Ikenberg, D. Wagner, and H. zur Hausen, Presence of human papillomavirus (HPV) in genital tumors, J. Invest. Dermatol. 83:265–285 (1984).
Groff, D.E., and W.D. Lancaster, Genetic analysis of the 3’ early region transformation and replication functions of bovine papillomavirus type 1, Virol. 150:221–230 (1986).
Grussendorf, E.I., and H. zur Hausen, Localization of viral DNA replication in sections of human warts by nucleic acid hybridization with complementary RNA of human papillomavirus type 1, Arch. Dermatol. Res. 264:55–63(1979).
Guis, D., and L. Laimins, Constitutive and inducible expression of the HPV-18 enhancer, p. 126, in: “Sixth International Papillomavirus Workshop,” W.D. Lancaster and A.B. Jenson, eds., Georgetown University (1987).
Hirochika, H., T.R. Broker, and L.T. Chow, Enhancers and trans-acting E2 transcriptional factors of papillomaviruses, J. Virol. 61:2599–2606 (1987).
Hirt, B., Selective extraction of polyoma DNA from infected mouse cell cultures, J. Mol. Biol. 26:365–369 (1967).
Howley, P.M., M.A. Israil, M.F. Law, and M.A. Martin, A rapid method for detecting and mapping homology between heterologous DNAs, J. Biol. Chem. 254:4876–4883 (1979).
Komly, C.A., F. Breitburd, 0. Croissant, and R.E. Streek, The L2 open reading frame of human papillomavirus type la encodes a minor structural protein carrying type specific antigens, J. Virol. 60:813–816 (1986).
Koss, L.G., and G.R. Durfee, Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia, Ann. New York Acad. Sci. 63:1245 (1956).
Kovesdi, I., M. Satake, K. Furukawa, R. Reichel, Y. Ito, and J.R. Nevins, A factor discriminating between the wildtype and a mutant polyomavirus enhancer, Nature 328:87–89 (1987).
Kreider, J.W., M.K. Howett, N.L. Lill, G.L. Bartlett, R.J. Zaino, T.V. Sedlacek, and R. Mortel, In vitro transformation of human skin with human papillomavirus type 11 from condylomata acuminata, J. Virol. 59:369–376 (1986).
Kreider, J.W., M.K. Howett, S.A. Wolfe, G.L. Bartlett, R.J. Zaino, T.V. Sedlacek, and R. Mortel, Morphological transformation of human uterine cervix with papillomavirus from condylomata acuminata, Nature. 317:639–640 (1985).
Kryszke, M.H., P. Jacques, and M. Yaniv, Induction of a factor that binds to the polyomavirus A enhancer on differentiation of embryonal carcinoma cells, Nature. 328:254–256 (1987).
Kurman, R.J., A.B. Jenson, and W.D. Lancaster, Papillomavirus infection of the cervix: 2. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins, Am. J. Surg. Path. 7:39–52 (1983).
Kurman, R.J., K.H. Shah, W.D. Lancaster, and A.B. Jenson, Immunoperox- idase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas, Am. J. Obstet. Gynecol. 140:931–935 (1981).
Lambert, P.F., B.A. Spalholz, and P.M. Howley, A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator, Cell. 50:69–78 (1987).
Lancaster, W.D., C. Castellano, C. Santos, G. Delgado, R.J. Kurman, and A.B. Jenson, Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites, Am. J. Obstet. Gynecol. 154:115–119 (1986).
Lancaster, W.D., R.J. Kurman, L.E. Sang, S. Perry, and A.B. Jenson, Human papillomavirus: detection of viral DNA sequences and evidence for molecular heterogeneity in metaplasias and dysplasias of the uterine cervix, Intervirol. 20:202–212 (1983).
Lehn, H., P. Krieg, and G. Sauer, Papillomavirus genomes in human cervical tumors: Analysis of their transcriptional activity, Proc. Natl. Acad. Sci. USA 82:5540–5544 (1985).
Lorincz, A.T., W.D. Lancaster, and G.F. Temple, Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix, J. Virol. 58:225–229 (1986).
Lorincz, A.T., G.F. Temple, J.A. Patterson, A.B. Jenson, and W.D. Lancaster, Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix, Obstet. Gynecol. 68:508–512 (1986).
Lusky, M., and M.R. Botchan, Genetic analysis of bovine papillomavirus type 1 transacting replication factors, J. Virol. 53:955–965 (1985).
Lusky, M., and M.R. Botchan, Transient replication of bovine papillomavirus type 1 plasmids: cis and trans requirements, Proc. Natl. Acad. Sci. USA 83:3609–3613 (1986).
Lyon, J., L. Rosl, and H. Zentgraf, Origin of replication in episomal bovine papillomavirus type 1 DNA isolated from transformed cells, EMBO J. 3:2173–2178 (1984).
Marmur, J., R. Rownd, and C.L. Schildkraut, Prog. Nucleic Acid Res. 1:231 (1963).
Mathews, R.E., Classification and nomenclature of viruses, Intervirol. 17:1–199 (1982).
Matsukura, T., T. Kanda, A. Furuno, H. Yoshikawa, T. Kawana, and K. Yoshike, Cloning of monomeric human papillomavirus type 16 DNA integreated within cell DNA from a cervical carcinoma, J. Virol. 58:979982 (1986).
Meisels, A., and R. Fortin, Condylomatous lesions of the cervix and vagina, I. Cytologic patterns, Acta. Cytol. 20:505–509 (1976).
Meisels, A., R. Fortin, and M. Roy, Condylomatous lesions of the cervis, II. Cytologic, colposcopic and histopathologic study, Acta. Cytol. 21:379–390 (1977).
Meisels, A., C. Morin, and M. Casas-Cordero, Human papillomavirus infection of the uterine cervix, Int. J. Gynecol. Path. 1:75–94 (1982).
Ostrow, R.S., K.R. Zachow, and A.J. Faras, Molecular coning and nucleotide sequence analysis of several naturally occurring HPV-5 deletion mutant genomes, Virol. 158:235–238 (1987).
Pater, M.M., and A. Pater, Human papillomavirus types 16 and 18 sequences in carcinoma cell lines, Virol. 145:313–318 (1985).
Pfister, H., Biology and biochemistry of papillomaviruses, Rev. Physiol. Biochem. Pharmacol. 99:111–181 (1984).
Rando, R.F., D.E. Groff, J.G. Chirikjian, and W.D. Lancaster, Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma, J. Virol. 57:353–356 (1986).
Rando, R.F., T.V. Sedlacek, J. Hunt, A.B. Jenson, R.J. Kurman, and W.D. Lancaster, Verrucous carcinoma of the vulva associated with an unusual type 6 human papillomavirus, Obstet. and Gynecol. 67:70s-75s (1986).
Rando, R.F., W.D. Lancaster, P. Han, and C. Lopez, The noncoding region of HPV-6vc contains two distinct transcriptional enhancing elements, Virol. 155:545–556 (1986).
Rando, R.F., Naturally occuring deletion mutants of HPV-16 isolated from a precancerous vaginal lesion, Virol. submitted (1987).
Reid, R., M. Greenberg, A.B. Jenson, M. Husain, J. Willett, Y. Daoud, G. Temple, and A.T. Lorincz, Sexually transmitted paillomaviral infections. I. The anatomic distribution and pathologic grad of neoplastic lesions associated with different viral types, Am. J. Obstet. Gynecol. 156:212–222 (1987).
Reid, R., C.R. Laverty, M. Coppleson, W. Isarangkul, and E. Hills, Noncondylomatous cervical wart virus infection, Obstet. Gynecol. 55: 476–483 (1980).
Rowson, K.E.K., and B.W.J. Mahy, Humanpapova (wart) virus, Bacteriol. Rev. 31:100 (1967).
Sanger, F., and A.R. Coulson, A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase, J. Mol. Biol. 94:441–448 (1975).
Sarver, N., M.S. Rabson, Y.C. Yang, J.C. Byrne, and P.M. Howley, Localization and analysis of bovine papillomavirus type 1 transforming functions, J. Virol. 52:377–388 (1984).
Schiller, J.T., W.C. Vass, and D.R. Lowry, Identification of a second transforming region in bovine papillomavirus DNA, Proc. Natl. Acad. Sci. USA 81:7880–7884 (1984).
Schiller, J.T., W.C. Vass, K.H. Vousdan, and D.R. Lowy, The E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene, J. Virol. 57:1–6 (1986).
Schwarz, E., U.K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen, Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature. 314: 111–114 (1985).
Smotkin, D., and F.O. Wettstein, The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein, J. Virol. 61:1686–1689 (1987).
Southern, E.M., Detection of specific sequences among DNA fragments separated by gel electrophoresis, J. Mol. Biol. 98:503–517 (1975).
Spalholz, B.A., Y.C. Yang, and P.M. Howley, Transactivation of a bovine papillomavirus transcriptional regulatory element by the E2 gene product, Cell. 42:183–191 (1985).
Stoler, M.H., and T.R. Broker, In situ hybridization detection of human papillomavirus DNA and messenger RNA in genital condylomas and a cervical carcinoma, Hum. Path. 17:1250–1258 (1986).
Toon, P.G., J.R. Arrand, L.P. Wilson, and D.S. Sharp, Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia, Br. Med. J. 293:1261–1264 (1986).
Tsunokawa, Y., N. Takebe, S. Nozawa, T. Kasamatsu, L. Gissman, H. zur Hausen, M. Terada, and T. Sugimura, Presence of human papillomavirus type-16 and type-18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients, Int. J. Cancer. 37:499–503 (1986).
Wagner, D., H. Ikenberg, N. Boehm, and L. Gissmann, Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization, Obstet. Gynecol. 64:767–772 (1984).
Wettstein, F.O., and J.G. Stevens, Variable-sized free episomes of shope papillomavirus DNA are present in all non-virus producing neoplasms and integrated episomes are detected in some, Proc. Natl. Acad. Sci. USA 79:790–794 (1982).
Wickenden, C., A.D. Malcolm, A. Steele, and D.V. Coleman, Screening for wart virus infection in normal and abnormal cervices by DNA hybridization of cervical scrapes, Lancet. 1:65–67 (1985).
Winkler, B., V. Capa, W. Reumann, A. Ma, R. La Porta, S. Reilly, P.M. Green, R.M. Richart, and C.P. Crum, Human papillomavirus infection of the esophagus. A clinicopathologic study with demonstration of papillomaviurs antigen by the immunoperoxidase technique, Cancer. 55:149–155 (1985).
Yang, Y.C., B.A. Spalholz, M.S. Rabson, and P.M. Howley, Dissociation of transforming and trans-activation functions for bovine papillomavirus type 1, Nature. 318:575–577 (1985).
Yee, C., I. Krishnan-Hewlett, C.C. Baker, R. Schlegel, and P.M. Howley, Presence and expression of HPV sequences in human cervical carcinoma cell lines, Am. J. Path. 119:361–366 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Rando, R.F. (1989). Nucleic Acid Hybridization as a Diagnostic Tool for the Detection of Human Papillomaviruses. In: Kleger, B., Jungkind, D., Hinks, E., Miller, L.A. (eds) Rapid Methods in Clinical Microbiology. Advances in Experimental Medicine and Biology, vol 263. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0601-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0601-6_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7886-3
Online ISBN: 978-1-4613-0601-6
eBook Packages: Springer Book Archive